Home > Qtrly Results > NATCO PHARMA

NATCO PHARMA
Quarterly Results Analysis [Jun2026]

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹735 Cr ₹739 Cr ₹647 Cr ₹1,363 Cr ₹1,329 Cr ₹1,221 Cr ₹475 Cr ₹1,371 Cr
Expenses ₹549 Cr ₹612 Cr ₹489 Cr ₹784 Cr ₹758 Cr ₹673 Cr ₹436 Cr ₹567 Cr
Operating Income ₹187 Cr ₹128 Cr ₹159 Cr ₹579 Cr ₹571 Cr ₹548 Cr ₹39 Cr ₹804 Cr
Other Income ₹59 Cr ₹78 Cr ₹58 Cr ₹100 Cr ₹62 Cr ₹66 Cr ₹176 Cr ₹64 Cr
Interest ₹13 Cr ₹11 Cr ₹10 Cr ₹13 Cr ₹3 Cr ₹10 Cr ₹4 Cr ₹4 Cr
Depreciation ₹47 Cr ₹50 Cr ₹46 Cr ₹52 Cr ₹58 Cr ₹98 Cr ₹47 Cr ₹46 Cr
Profit Before Tax ₹186 Cr ₹144 Cr ₹161 Cr ₹614 Cr ₹572 Cr ₹506 Cr ₹164 Cr ₹818 Cr
Profit After Tax ₹122 Cr ₹233 Cr ₹140 Cr ₹518 Cr ₹480 Cr ₹406 Cr ₹132 Cr ₹677 Cr
EPS ₹11.54 ₹14.97 ₹8.46 ₹28.96 ₹26.85 ₹22.72 ₹7.43 ₹37.84
Industry Peers & Returns1W1M1Y
NATCO PHARMA -3.4% -8.3% -2.8%
SUN PHARMACEUTICAL INDUSTRIES 0.5% -4% 15.7%
DIVIS LABORATORIES 9.1% 18.2% 47.1%
TORRENT PHARMACEUTICALS 3.6% 3.4% 36.4%
CIPLA -1.2% -3.3% -10.8%
DR REDDYS LABORATORIES -1.4% 2.9% -8%
MANKIND PHARMA 0.5% -7.4% -7.3%
LUPIN -0.7% -10.1% 9.6%
ZYDUS LIFESCIENCES 7.8% 6.4% 20.3%

NATCO PHARMA Quarterly Revenues

Revenues
Q-o-Q

-0.53 %

Y-o-Y

-44.68 %

Quarters Revenues % Change
Jun2026 ₹735 Cr
-0.53
Mar2026 ₹739 Cr
14.18
Dec2025 ₹647 Cr
-52.51
Sep2025 ₹1,363 Cr
2.57
Jun2025 ₹1,329 Cr
8.84
Mar2025 ₹1,221 Cr
157.16
Dec2024 ₹475 Cr
-65.37
Sep2024 ₹1,371 Cr -

NATCO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

46.16 %

Y-o-Y

-67.34 %

Quarters Operating Profit % Change
Jun2026 ₹187 Cr
46.16
Mar2026 ₹128 Cr
-19.60
Dec2025 ₹159 Cr
-72.60
Sep2025 ₹579 Cr
1.44
Jun2025 ₹571 Cr
4.18
Mar2025 ₹548 Cr
1,312.63
Dec2024 ₹39 Cr
-95.18
Sep2024 ₹804 Cr -
Operating Margins
Q-o-Q

46.99 %

Y-o-Y

-40.96 %

Quarters Operating Margin% % Change
Jun2026 25.37%
46.99
Mar2026 17.26%
-29.61
Dec2025 24.52%
-42.29
Sep2025 42.49%
-1.12
Jun2025 42.97%
-4.28
Mar2025 44.89%
449.45
Dec2024 8.17%
-86.07
Sep2024 58.66% -

NATCO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-47.62 %

Y-o-Y

-74.56 %

Quarters Profit After Tax % Change
Jun2026 ₹122 Cr
-47.62
Mar2026 ₹233 Cr
66.17
Dec2025 ₹140 Cr
-72.89
Sep2025 ₹518 Cr
7.83
Jun2025 ₹480 Cr
18.30
Mar2025 ₹406 Cr
206.65
Dec2024 ₹132 Cr
-80.43
Sep2024 ₹677 Cr -
PAT Margins
Q-o-Q

-47.36 %

Y-o-Y

-54.01 %

Quarters PAT Margin(%) % Change
Jun2026 16.62 %
-47.36
Mar2026 31.57 %
45.55
Dec2025 21.69 %
-42.92
Sep2025 38 %
5.15
Jun2025 36.14 %
8.69
Mar2025 33.25 %
19.22
Dec2024 27.89 %
-43.47
Sep2024 49.34 % -

NATCO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-22.91 %

Y-o-Y

-57.02 %

Quarters EPS % Change
Jun2026 ₹11.54
-22.91
Mar2026 ₹14.97
76.95
Dec2025 ₹8.46
-70.79
Sep2025 ₹28.96
7.86
Jun2025 ₹26.85
18.18
Mar2025 ₹22.72
205.79
Dec2024 ₹7.43
-80.36
Sep2024 ₹37.84 -

You may also like the below Video Courses